Intracisternal delivery of NFκB-inducible scAAV2/9 reveals locoregional euroinflammation induced by systemic kainic acid treatment

Frontiers in Molecular Neuroscience

Volumn 7, Issue DEC, 2014, Pages

  Bockstael, Olivier ^a   Tenenbaum, Liliane ^b   Dalkara, Deniz ^c,d,e   Melas, Catherine ^a   De Witte, Olivier ^a   Levivier, Marc ^b   Chtarto, Abdelwahed ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c INSERM   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e CNRS   (France)

Author keywords

AAV; Cerebrospinal fluid; Cisterna magna; Inducible vector; Neuroinflammation

Indexed keywords

ELONGATION FACTOR 2; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

AGE; ANIMAL MODEL; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ARTICLE; BRAIN DEPTH RECORDING; CONTROLLED STUDY; ELECTROPHYSIOLOGICAL PROCEDURES; FOOD INTAKE; FORCED SWIM TEST; MOUSE; NERVE CELL PLASTICITY; NERVE POTENTIAL; NONHUMAN; PROTEIN EXPRESSION; RAT; SYNAPTIC EFFICACY;

EID: 84938271246     PISSN: 16625099     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnmol.2014.00092     Document Type: Article

References (31)

1. Arima, H., Yamamoto, N., Sobue, K., Umenishi, F., Tada, T., Katsuya, H., et al. (2003). Hyperosmolar mannitol simulates expression of aquaporins 4 and 9 through a p38 mitogen-activated protein kinase-dependent pathwayin rat astrocytes. J. Biol. Chem. 278, 44525-44534. doi: 10.1074/jbc.M304368200.
2. Bockstael, O., Melas, C., Pythoud, C., Levivier, M., McCarty, D., Samulski, R. J., et al. (2012). Rapid transgene expression in multiple precursor cell types of adult rat subventricular zone mediated by adeno-associated type 1 vectors. Hum. Gene Ther. 23, 742-753. doi: 10.1089/hum.2011.216.
3. Brown, G. C., and Neher, J. J. (2014). Microglial phagocytosis of live neurons. Nat.Rev. Neurosci. 15,209-216. doi: 10.1038/nrn3710.
4. Bucher, T., Colle, M. A., Wakeling, E., Dubreil, L., Fyfe, J., Briot-Nivard, D., et al. (2013). scAAV2/9 intracisternal delivery results in efficient gene transfer to the central nervous system of a feline model of motor neuron disease. Hum. Gene Ther. 24, 670-682. doi: 10.1089/hum.2012.218.
5. Chtarto, A., Bockstael, O., Gebara, E., Vermoesen, K., Melas, C., Pythoud, C., et al. (2013).An adeno-associatedvirus-basedintracellular sensor ofpathological nuclear factor-kappaB activation for disease-inducible gene transfer. PLoS ONE 8:e53156. doi: 10.1371/journal.pone.0053156.
6. Dalkara, D., Byrne, L. C., Lee, T., Hoffmann, N. V., Schaffer, D. V., and Flannery, J. G. (2012). Enhanced gene delivery to the neonatal retina through systemic administration of tyrosine-mutated AAV2/9. Gene Ther. 19, 176-181. doi: 10.1038/gt.2011.163.
7. Dehay, B., Dalkara, D., Dovero, S., Li, Q., and Bezard, E. (2012). Systemic scAAV2/9 variantmediatesbraintransductionin newbornrhesusmacaques. Sci. Rep. 2:253. doi: 10.1038/srep00253.
8. Dexter, D. T., and Jenner, P. (2013). Parkinson disease: from pathology to molecular disease mechanisms. Free Radic. Biol. Med. 62, 132-144. doi: 10.1016/j.freeradbiomed.2013.01.018.
9. Duque, S., Joussemet, B., Riviere, C., Marais, T., Dubreil, L., Douar, A. M., etal. (2009). Intravenous administration of self-complementary AAV2/9 enables transgene delivery to adult motor neurons. Mol. Ther. 17, 1187-1196. doi: 10.1038/mt.2009.71.
10. Foust, K. D., Nurre, E., Montgomery, C. L., Hernandez, A., Chan, C. M., and Kaspar, B. K. (2009). Intravascular AAV2/9 preferentially targets neonatal neurons and adult astrocytes. Nat. Biotechnol. 27, 59-65. doi: 10.1038/nbt.1515.
11. Fu, H., Dirosario, J., Kang, L., Muenzer, J., and Mccarty, D. M. (2010). Restoration of central nervous system alpha-N-acetylglucosaminidase activity and therapeutic benefits in mucopolysaccharidosis IIIB mice by a single intracisternal recombi­nant adeno-associated viral type 2 vector delivery. J. Gene Med. 12, 624-633. doi: 10.1002/jgm.1480.
12. Fu, H., Dirosario, J., Killedar, S., Zaraspe, K., and Mccarty, D. M. (2011). Cor­rection of neurological disease of mucopolysaccharidosis IIIB in adult mice by rAAV2/9 trans-blood-brain barrier gene delivery. Mol. Ther. 19, 1025-1033. doi: 10.1038/mt.2011.34.
13. Fu, H., Muenzer, J., Samulski, R. J., Breese, G., Sifford, J., Zeng, X., et al. (2003). Self- complementary adeno-associated virus serotype 2 vector: global distribution and broad dispersion of AAV-mediated transgene expression in mouse brain. Mol. Ther. 8,911-917. doi: 10.1016/j.ymthe.2003.08.021.
14. Gray, S. J., Matagne, V., Bachaboina, L., Yadav, S., Ojeda, S. R., and Samulski, R. J. (2011). Preclinical differences of intravascular AAV2/9 delivery to neurons and glia: a comparative study of adult mice and nonhuman primates. Mol. Ther. 19, 1058-1069. doi: 10.1038/mt.2011.72.
15. Gray, S. J., Nagabhushan, K. S., McCown, T. J., and Jude, S. R. (2013). Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathe­cal AAV administration in non-human primates. Gene Ther. 20, 450-459. doi: 10.1038/gt.2012.101.
16. Iliff, J. J., Wang, M., Liao, Y., Plogg, B. A., Peng, W., Gundersen, G. A., et al. (2012). A perivascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Sci. Transl. Med. 4:147ra111. doi: 10.1126/scitranslmed.3003748.
17. Liu, L., and Duff, K. (2008). A technique for serial collection of cerebrospinal fluid from the cisterna magna in mouse. J. Vis. Exp. 21, 960. doi: 10.3791/960.
18. Lock, M., McGorray, S., Auricchio, A., Ayuso, E., Beecham, E. J., Blouin-Tavel, V., et al. (2010). Characterization of a recombinant adeno-associated virus type 2. Reference Standard Material. Hum. Gene Ther. 21, 1273-1285. doi: 10.1089/hum.2009.223.
19. London, A., Cohen, M., and Schwartz, M. (2013). Microglia and monocyte- derived macrophages: functionally distinct populations that act in concert in CNS plasticity and repair. Front. Cell. Neurosci. 7:34. doi: 10.3389/fncel.2013.00034.
20. Mccarty, D. M., Dirosario, J., Gulaid, K., Muenzer, J., and Fu, H. (2009). Mannitol-facilitated CNS entry of rAAV2 vector significantly delayed the neu­rological disease progression in MPS IIIB mice. Gene Ther. 16, 1340-1352. doi: 10.1038/gt.2009.85.
21. Mccarty, D. M., Fu, H., Monahan, P. E., Toulson, C. E., Naik, P., and Samulski, R. J. (2003). Adeno-associated virus terminal repeat (TR) mutant generates self- complementary vectors to overcome the rate-limiting step to transduction in vivo. GeneTher. 10, 2112-2118. doi: 10.1038/sj.gt.3302134.
22. Pardridge, W. M. (2011). Drug transport in brain via the cerebrospinal fluid. Fluids Barriers CNS 8:7. doi: 10.1186/2045-8118-8-7.
23. Rong, Y., and Baudry, M. (1996). Seizure activity results in a rapid induction of nuclear factor-kappa B in adult but not juvenile rat limbic structures. J. Neurochem. 67, 662-668. doi: 10.1046/j.1471-4159.1996.67020662.x
24. Samaranch, L., Salegio, E. A., San, S. W., Kells, A. P., Bringas, J. R., Forsayeth, J., et al. (2013). Strong cortical and spinal cord transduction after AAV7 andAAV2/9 delivery into the cerebrospinal fluid of nonhuman primates. Hum. Gene Ther. 24, 526-532. doi: 10.1089/hum.2013.005.
25. Samaranch, L., Salegio, E. A., San, S. W., Kells, A. P., Foust, K. D., Bringas, J. R., etal. (2012). Adeno-associated virus serotype 9 transduction in the cen­tral nervous system of nonhuman primates. Hum. Gene Ther. 23, 382-389. doi: 10.1089/hum.2011.200.
26. Samaranch, L., San, S. W., Kells, A. P., Salegio, E. A., Heller, G., Bringas, J. R., et al. (2014). AAV2/9-mediated expression of a non-self protein in nonhu­man primate central nervous system triggers widespread neuroinflammation driven by antigen-presenting cell transduction. Mol. Ther. 22, 329-337. doi: 10.1038/mt.2013.266.
27. Schwartz, M., and Baruch, K. (2014). The resolution of neuroinflammation in neurodegeneration: leukocyte recruitment via the choroid plexus. EMBO J. 33, 7-22. doi: 10.1002/embj.201386609.
28. Somera-Molina, K. C., Nair, S., Van Eldik, L. J., Watterson, D. M., and Wainwright, M. S. (2009). Enhanced microglial activation and proinflamma- tory cytokine upregulation are linked to increased susceptibility to seizures and neurologic injury in a two-hit’ seizure model. Brain Res. 1282, 162-172. doi: 10.1016/j.brainres.2009.05.073.
29. Vermoesen, K., Smolders, I., Massie, A., Michotte, Y., and Clinckers, R. (2010). The control of kainic acid-induced status epilepticus. Epilepsy Res. 90, 164-166. doi: 10.1016/j.eplepsyres.2010.04.001.
30. Williams, P. A., White, A. M., Clark, S., Ferraro, D. J., and Swiercz, W. (2009). Development of spontaneous recurrent seizures after kainate-induced status epilepticus. J. Neurosci. 29, 2103-2112. doi: 10.1523/JNEUR0SCI.0980-08.2009.
31. Zhong, L., Li, B., Jayandharan, G., Mah, C. S., Govindasamy, L., Agbandje-McKenna, M., et al. (2008). Tyrosine-phosphorylation of AAV2 vectors and its consequences on viral intracellular trafficking and transgene expression. Virology 381,194-202. doi: 10.1016/j.virol.2008.08.027